Pasi Janne
机构: Dana Farber Cancer Institute
每年引用次数
引用次数
引用: 134,728
H-指数: 163
I10-指数 : 547
出版物: 1,257
Comparison of the Efficacy of Dacomitinib v Erlotinib for NSCLC Pts with Del 19/L858R
Suresh S Ramalingam , Kenneth J O'Byrne , Tony Mok , Michael Boyer
JOURNAL OF THORACIC ONCOLOGY 10 ( 9) S278 -S278
2015
Secondary C805S Mutation in HER2 Gene Confers Acquired Resistance to HER2 Kinase Inhibitors in HER2 Mutant Lung Cancer
Takayuki Kosaka , Hideki Endoh , Claire Repellin , Junko Tanizaki
JOURNAL OF THORACIC ONCOLOGY 10 ( 9) S296 -S296
2015
Chemotherapy for Locally Advanced and Metastatic Pulmonary Carcinoid Tumors
Curtis R Chong , Lori J Wirth , Mizuki Nishino , Aileen B Chen
PANCREAS 44 ( 2) 352 -352
2015
Drug Discovery for Atypical Pulmonary Carcinoid Using a Library of Targeted Agents
Curtis R Chong , Bruce E Johnson , Pasi A Jaenne
PANCREAS 44 ( 2) 347 -347
2015
Pathologic Classification of Pulmonary Carcinoid Cell Lines
Curtis R Chong , Ilona Linnoila , Pasi A Jaenne , Bruce E Johnson
PANCREAS 44 ( 2) 347 -347
2015
EXPLORATION OF THE RELATIONSHIP BETWEEN NEUTROPHIL COUNT AND CLINICAL CONSEQUENCES IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) RECEIVING SELUMETINIB PLUS DOCETAXEL: PREDICTED EFFECT OF PRIMARY PROPHYLACTIC GCSF
Pasi A Jaenne , Patricia Lorusso , Delyth Clemett , Susan Lovick
JOURNAL OF THORACIC ONCOLOGY 8 S1200 -S1201
2013
EFFICACY OF STANDARD CARE FOR SECOND-LINE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) BY KRAS MUTATION STATUS: OBSERVATIONS ON MEK INHIBITOR ENHANCEMENT OF CHEMOTHERAPY
Pasi A Jaenne , Delyth Clemett , Helen Mann , Ian Smith
JOURNAL OF THORACIC ONCOLOGY 8 S196 -S197
2013
A PROSPECTIVE INTERNET-BASED STUDY OF PATIENTS WITH LUNG CANCER HARBORING BASELINE EGFR T790M TO IDENTIFY GERMLINE CARRIERS AND CHARACTERIZE FAMILIAL RISK
Geoffrey R Oxnard , Jennifer C Heng , Irene R Rainville , Alicia L Sable-Hunt
JOURNAL OF THORACIC ONCOLOGY 8 S350 -S350
2013
THE SELECT-1 STUDY DESIGN: SELUMETINIB IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF KRAS MUTATION-POSITIVE LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Pasi A Jaenne , Helen Mann , Ian Smith
JOURNAL OF THORACIC ONCOLOGY 8 S1201 -S1201
2013
DEVELOPMENT OF A CLINICAL-GRADE QUANTITATIVE ASSAY FOR NON-INVASIVE MEASUREMENT OF TUMOR GENOTYPE IN CELL-FREE PLASMA DNA (CFDNA) USING NEXT-GENERATION QUANTITATIVE GENOTYPING
Geoffrey R Oxnard , Cloud P Paweletz , Yanan Kuang , Melissa M Messineo
JOURNAL OF THORACIC ONCOLOGY 8 S1099 -S1099
2013
A PRACTICE-BASED ANALYSIS TO GAUGE THE FEASIBILITY OF GENOTYPE-DIRECTED INDUCTION THERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
Jack Varon , Raymond H Mak , Stephanie H Cardarella , Pasi A Jaenne
JOURNAL OF THORACIC ONCOLOGY 8 S1215 -S1216
2013
T790M mutation and c-MET amplification might be correlated to TTP of EGFR-TKI in NSCLC
Y Wu , TS Mok , H Chen , X Zhang
Journal of Clinical Oncology 26 8107 -8107
1
2008
Meningeal carcinomatosis in lung cancer. Case 2. Carcinomatous meningitis
JANNE PA
J Clin Oncol 18 2927 -2929
3
2000
Crizotinib safety profile in elderly and non-elderly patients (pts) with advanced ALK plus non-small cell lung cancer (NSCLC)
F Blackhall , AT Shaw , PA Jaenne , DW Kim
EUROPEAN JOURNAL OF CANCER 49 S821 -S821
2
2013
Digital Mutation Scanning by Using an Enhanced Ratio of Signals
E Castellanos-Rizaldos , C Paweletz , GR Oxnard , H Mamon
JOURNAL OF MOLECULAR DIAGNOSTICS 16 ( 6) 773 -773
2014
Multiplex RNA/miRNA in Situ Detection in Cancer Tumor Cells Captured by an Innovative Circulating Tumor Cell (CTC) Filter-Based Device
A Lin , M Yanagita , S Levinson , J Pache
JOURNAL OF MOLECULAR DIAGNOSTICS 14 ( 6) 725 -726
2012
EGER gene amplification is invariably associated with exon 19 deletion in non-small cell lung carcinoma
LM Sholl , AJ Iafrate , B Yeap , A Holmes
LABORATORY INVESTIGATION 88 351A -351A
2008
TAK-701, a humanized monoclonal antibody to HGF, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation
Wataru Okamoto , Isamu Okamoto , Kaoru Tanaka , Tokuzo Arao
Cancer Research 71 ( 8_Supplement) 1731 -1731
1
2011
Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
George N Naumov , Monique B Nilsson , Tina Cascone , Alexandra Briggs
Clinical Cancer Research 15 ( 10) 3484 -3494
342
2009
Phase I dose escalation study of the pan-HER inhibitor, PF00299804, in patients with advanced malignant solid tumors
David S Boss , Carolyn Britten , Pasi Jannë , Ross Camidge
Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs 217 -217
2009